In addition, loss of ERα expression and CAFs is linked to a poor response of BC cells to TAM, with the suppression of the activity of CD63+ CAFs to enhance TAM sensitivity in BC cells, in vivo (Gao et al., 2020). Here, ESR1 is linked to breast cancer.